Trends in Biotechnology · Nov 16, 2026
Growth factor printing into fusing cell spheroids to engineer spatially complex tissues
By Wu JY, Correia C, Gonnella G et al.
The bioprinting platform for patterned presentation of growth factors alongside cell spheroids for engineering of spatially complex tissue constructs is currently at technology readiness level 3, with experimental proof of concept demonstrated in a laboratory setting. In considering spheroids as biological building blocks for tissue engineering, it is advantageous to use less mature cellular spheroids for their more comprehensive fusion and superior extracellular matrix deposition. The technology makes it possible to begin with a phenotypically homogenous population of spheroids, pattern inks that sustain the release of key instructive cues (growth factors) in a biomaterial-minimalistic manner, ultimately directing regionally distinct cell fates in situ. In this study, we have used the osteochondral gradient as a proof of concept, but the approach could be applied to numerous different tissue and organ types. If the envisioned application of these engineered constructs is for regenerative implantation, it will be necessary to minimize, or to predict and accommodate, shape changes of the overall tissue. In vivo tissue integration and stability should also be investigated with longer term animal studies. On the contrary, such tissues can already provide an advanced, cell-dense in vitro model of the osteochondral interface. Future work can improve the efficiency of the bioprinting and tissue fabrication process to enhance throughput without sacrificing complexity.
doi.org/10.1016/j.tibtech.2026.10.011PubMed 43039748Interventions